coronary herat disease after percutaneous coronary intervention
Conditions
Interventions
treatmentgroup:xinyue capsule
Sponsors
Xiyuan Hospital of China Academy of Chinese Medical Sicences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) patients who was suffered coronary heart disease and was accepted sucessful PCI were inclusion; (2) The inclusion time is from 3 months to 1 year after PCI; (3) The age is between 18 and 75 years; (4) The degree of heart function is I or II (NYHA); (5) Signed informed consent.
Exclusion criteria
Exclusion criteria: (1) concomitant affliction with severe complications including hepatic, renal, and hematopoietic dysfunction, psychiatric disorders, or cancers; (2) poor control of blood pressure or blood glucose; (3) absence of written informed consent, unwillingness to participate in follow-up, or refusal to receive treatmentwith study drugs; (4) pregnancy or breastfeeding; (5) concurrent enrollment in another clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cardiac death;non fatal AMI;revascularization;all-cause death;rehosptial for ACS;stroke;Pulmonary embolism;Peripheral vascular events; | — |
Secondary
| Measure | Time frame |
|---|---|
| ejcetion fraction;B - type natriuretic peptide;high-sensitivity c-reactive protein;Dyslipidemia;SF-36;electrocardiogram; | — |
Countries
China
Contacts
Public ContactShi Dazhuo
Outcome results
None listed